X

XVIVO Perfusion AB

72 employees

XVIVO Perfusion develops optimized solutions for organ, tissue, and cell preservation in connection with transplantation.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical Device
Heart preservation
Organ perfusion
Machine perfusion
Lung transplantation
Transplantation
Research
Lung preservation
EVOP
Organ preservation
EVLP
Ex-vivo lung perfusion
Medical
Research collaboration

Date founded

1998

Funding rounds raised

Total raised

$63K

from 1 investors over 1 rounds

X

XVIVO Perfusion AB raised $63K on November 1, 2014

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ